๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Drug delivery: A key factor in realising the full therapeutic potential of drugs

โœ Scribed by William N. Charman; Hak-Kim Chan; Barrie C. Finnin; Susan A. Charman


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
164 KB
Volume
46
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

โœฆ Synopsis


Drug delivery is a key factor contributing to the commercial and therapeutic potential of many drugs and related products. Drug delivery underpins the development of new chemical entities, and it is the driving force behind the development of many new devices and formulation-based projects.

There are many exciting drug delivery projects being undertaken in commercial organisations, universities and research institutes throughout Australia. This article describes projects in the field of lipids and oral drug delivery, protein formulation and stability, aerosol drug delivery and transdermal drug delivery which are being undertaken in the authors' laboratories. It is hoped that these projects provide some insight into the scope and breadth of drug delivery research being conducted in ''The Antipodes. '' Drug Dev. Res. 46:316-327, 1999.


๐Ÿ“œ SIMILAR VOLUMES


A new drug delivery system with controll
โœ Suzuki, Yoshihisa ;Tanihara, Masao ;Nishimura, Yoshihiko ;Suzuki, Kyoko ;Kakimar ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 143 KB ๐Ÿ‘ 2 views

An ideal drug delivery system (DDS) releases an appropriate drug at specific locations and times. We tried to create a new antibiotic delivery system that releases gentamicin only when wounds are infected by Pseudomonas aeruginosa (P.A.). Exudate from the dorsal pouch of rats infected with P.A. show

Delivery of anticancer drugs via isolate
โœ Alexander L. Vahrmeijer; Marjolijn M. van der Eb; Jan Hein van Dierendonck; Pete ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 2 views

The prognosis of patients with irresectable liver metastases derived from colorectal cancer is invariably poor; unfortunately, these tumours show only minor responses to conventional anticancer agents. The best responses have been obtained by fluoropyrimidines delivered as continuous infusion into t